Project Number 5R01AG067325-03 Agency/Funding Organization NIA Funding Year 2022 View Full Project Details for Neuronal FXR as a potential therapeutic target for Alzheimer's disease Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category A. Molecular Pathogenesis and Physiology of Alzheimer's Disease and Alzheimer's Disease-related Dementias (AD/ADRDs) 6. Autophagy, Endocytosis and Membrane Trafficking c. Endosomal/Lysosomal Dysfunction Researcher and Organization Principal Investigator ANDERSEN, JULIE KAY Principal Investigator First Name JULIE KAY Principal Investigator Last Name ANDERSEN Awardee Organization BUCK INSTITUTE FOR RESEARCH ON AGING Awardee State California Contact PI Country United States Project Detail Funding Opportunity Announcement RFA-AG-20-013: Geroscience Approaches to Alzheimer's Disease (R01 Clinical Trial Not Allowed) FY Overall Cost $623,202 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official YANG, AUSTIN JYAN-YU
